Daniel Peterson: Difference between revisions
Notjusttired (talk | contribs) m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author") |
Notjusttired (talk | contribs) m (Text replacement - " \|" to " |") |
||
(One intermediate revision by the same user not shown) | |||
Line 83: | Line 83: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Alter, et al, 2012">{{Citation |last1 = Alter | | <ref name="Alter, et al, 2012">{{Citation | ||
| last1 = Alter | first1 = Harvey J. | authorlink1 = | |||
| last2 = Mikovits | first2 = Judy A. | authorlink2 = Judy Mikovits | |||
| last3 = Switzer | first3 = William M. | authorlink3 = | |||
| last4 = Ruscetti | first4 = Francis W. | authorlink4 = | |||
| last5 = Lo | first5 = Shyh-Ching | authorlink5 = | |||
| last6 = Klimas | first6 = Nancy | authorlink6 = Nancy Klimas | |||
| last7 = Komaroff | first7 = Anthony L. | authorlink7 = Anthony Komaroff | |||
| last8 = Montoya | first8 = Jose G. | authorlink8 = Jose Montoya | |||
| last9 = Bateman | first9 = Lucinda | authorlink9 = Lucinda Bateman | |||
| last10 = Levine | first10 = Susan | authorlink10 = Susan Levine | |||
| last11 = Peterson | first11 = Daniel | authorlink11 = Daniel Peterson | |||
| last12 = Levin | first12 = Bruce | authorlink12 = Bruce Levin | |||
| last13 = Hanson | first13 = Maureen R. | authorlink13 = Maureen Hanson | |||
| last14 = Genfi | first14 = Afia | authorlink14 = | |||
| last15 = Bhat | first15 = Meera | authorlink15 = | |||
| last16 = Zheng | first16 = HaoQiang | authorlink16 = | |||
| last17 = Wang | first17 = Richard | authorlink17 = | |||
| last18 = Li | first18 = Bingjie | authorlink18 = | |||
| last19 = Hung | first19 = Guo-Chiuan | authorlink19 = | |||
| last20 = Lee | first20 = Li Ling | authorlink20 = | |||
| last21 = Sameroff | first21 = Stephen | authorlink21 = | |||
| last22 = Heneine | first22 = Walid | authorlink22 = | |||
| last23 = Coffin | first23 = John | authorlink23 = | |||
| last24 = Hornig | first24 = Mady | authorlink24 = Mady Hornig | |||
| last25 = Lipkin | first25 = W. Ian | authorlink25 = Ian Lipkin | |||
| title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | | title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | ||
| journal = mBio | volume = 3 | issue = 5 | page = e00266–12 | | journal = mBio | volume = 3 | issue = 5 | page = e00266–12 | ||
Line 91: | Line 116: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="BatemanL, 2015">{{Citation |last1 = Bateman | | <ref name="BatemanL, 2015">{{Citation | ||
| last1 = Bateman | first1 = L. | authorlink1 = Lucinda Bateman | |||
| last2 = Darakjy | first2 = S. | authorlink2 = | |||
| last3 = Klimas | first3 = N. | authorlink3 = Nancy Klimas | |||
| last4 = Peterson | first4 = D. | authorlink4 = Daniel Peterson | |||
| last5 = Levine | first5 = S.M. | authorlink5 = Susan Levine | |||
| last6 = Allen | first6 = A. | authorlink6 = | |||
| last7 = Carlson | first7 = S.A. | authorlink7 = | |||
| last8 = Balbin | first8 = E.G. | authorlink8 = Elizabeth Balbin | |||
| last9 = Gottschalk | first9 = G. | authorlink9 = Gunnar Gottschalk | |||
| last10 = March | first10 = D. | authorlink10 = | |||
| title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | | title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | ||
Line 99: | Line 134: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Buchwald, 1992">{{Citation |last1 = Buchwald | | <ref name="Buchwald, 1992">{{Citation | ||
| last1 = Buchwald | first1 = Dedra | authorlink1 = Dedra Buchwald | |||
| last2 = Cheney | first2 = Paul R. | authorlink2 = Paul Cheney | |||
| last3 = Peterson | first3 = Daniel L. | authorlink3 = Daniel Peterson | |||
| last4 = Henry | first4 = Berch | authorlink4 = | |||
| last5 = Wormsley | first5 = Susan B. | authorlink5 = | |||
| last6 = Geiger | first6 = Ann | authorlink6 = | |||
| last7 = Ablashi | first7 = Dharam V. | authorlink7 = Dharam Ablashi | |||
| last8 = Salahuddin | first8 = S. Zaki | authorlink8 = | |||
| last9 = Saxinger | first9 = Carl | authorlink9 = | |||
| last10 = Biddle | first10 = Royce | authorlink10 = | |||
| last11 = Kikinis | first11 = Ron | authorlink11 = | |||
| last12 = Jolesz | first12 = Ferenc A. | authorlink12 = | |||
| last13 = Folks | first13 = Thomas | authorlink13 = | |||
| last14 = Balachandran | first14 = N. | authorlink14 = | |||
| last15 = Peter | first15 = James B. | authorlink15 = | |||
| last16 = Gallo | first16 = Robert C. | authorlink16 = | |||
| last17 = Komaroff | first17 = Anthony L. | authorlink17 = Anthony Komaroff | |||
| title = A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection | | title = A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection | ||
| journal = Annals of Internal Medicine | volume = 116 | issue = 2 | page = 103-113 | | journal = Annals of Internal Medicine | volume = 116 | issue = 2 | page = 103-113 | ||
Line 106: | Line 158: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Hornig, 2016">{{Citation |last1 = Hornig | | <ref name="Hornig, 2016">{{Citation | ||
| last1 = Hornig | first1 = M | authorlink1 = Mady Hornig | |||
| last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | |||
| last3 = Peterson | first3 = D | authorlink3 = Daniel Peterson | |||
| last4 = Knox | first4 = KK | authorlink4 = | |||
| last5 = Schultz | first5 = AF | authorlink5 = | |||
| last6 = Eddy | first6 = ML | authorlink6 = | |||
| last7 = Che | first7 = X | authorlink7 = | |||
| last8 = Lipkin | first8 = WI | authorlink8 = Ian Lipkin | |||
| title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | | title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | ||
| journal = Molecular Psychiatry | volume = 21 | issue = 2 | page = 261-9 | | journal = Molecular Psychiatry | volume = 21 | issue = 2 | page = 261-9 | ||
Line 113: | Line 173: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Hornig, 2017">{{Citation |last1 = Hornig | | <ref name="Hornig, 2017">{{Citation | ||
| last1 = Hornig | first1 = M | authorlink1 = Mady Hornig | |||
| last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | |||
| last3 = Eddy | first3 = ML | authorlink3 = | |||
| last4 = Che | first4 = X | authorlink4 = | |||
| last5 = Ukaigwe | first5 = JE | authorlink5 = | |||
| last6 = Peterson | first6 = DL | authorlink6 = Daniel Peterson | |||
| last7 = Lipkin | first7 = WI | authorlink7 = Ian Lipkin | |||
| title = Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations | | title = Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations | ||
| journal = Translational Psychiatry | volume = 7 | issue = 4 | page = | | journal = Translational Psychiatry | volume = 7 | issue = 4 | page = | ||
Line 120: | Line 187: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="KlimasNG, 2015">{{Citation |last1 = Klimas | | <ref name="KlimasNG, 2015">{{Citation | ||
| last1 = Klimas | first1 = N.G. | authorlink1 = Nancy Klimas | |||
| last2 = Ironson | first2 = G. | authorlink2 = | |||
| last3 = Carter | first3 = A. | authorlink3 = | |||
| last4 = Balbin | first4 = E. | authorlink4 = Elizabeth Balbin | |||
| last5 = Bateman | first5 = L. | authorlink5 = Lucinda Bateman | |||
| last6 = Felsenstein | first6 = D. | authorlink6 = Donna Felsenstein | |||
| last7 = Levine | first7 = S. | authorlink7 = Susan Levine | |||
| last8 = Peterson | first8 = D. | authorlink8 = Daniel Peterson | |||
| last9 = Chiu | first9 = K. | authorlink9 = | |||
| last10 = Allen | first10 = A. | authorlink10 = | |||
| last11 = Cunningham | first11 = K. | authorlink11 = | |||
| last12 = Gottschalk | first12 = C.G. | authorlink12 = Gunnar Gottschalk | |||
| last13 = Fletcher | first13 = M | authorlink13 = Mary Ann Fletcher | |||
| last14 = Hornig | first14 = M. | authorlink14 = Mady Hornig | |||
| last15 = Canning | first15 = C. | authorlink15 = | |||
| last16 = Komaroff | first16 = A.L. | authorlink16 = Anthony Komaroff | |||
| title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | ||
Line 128: | Line 211: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Levine, 1992">{{Citation |last1 = Levine | | <ref name="Levine, 1992">{{Citation | ||
| last10 = Salahuddin | first10 = Sayeef Z | authorlink10 = | | last1 = Levine | first1 = Paul H. | authorlink1 = Paul Levine | ||
| last2 = Jacobson | first2 = Steven | authorlink2 = | |||
| last3 = Pocinki | first3 = Alan G. | authorlink3 = Alan Pocinki | |||
| last4 = Cheney | first4 = Paul | authorlink4 = Paul Cheney | |||
| last5 = Peterson | first5 = Daniel | authorlink5 = Daniel Peterson | |||
| last6 = Connelly | first6 = Roger R | authorlink6 = | |||
| last7 = Weil | first7 = R | authorlink7 = | |||
| last8 = Robinson | first8 = SM | authorlink8 = | |||
| last9 = Ablashi | first9 = Dharam V | authorlink9 = Dharam Ablashi | |||
| last10 = Salahuddin | first10 = Sayeef Z | authorlink10 = | |||
| last11 = Pearson | first11 = GR | authorlink11 = | |||
| last12 = Hoover | first12 = R | authorlink12 = | |||
| title = Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome | | title = Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome | ||
| journal = Archives of Internal Medicine | volume = 152 | issue = 8 | page = 1611-1616 | | journal = Archives of Internal Medicine | volume = 152 | issue = 8 | page = 1611-1616 | ||
Line 137: | Line 231: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Levine, 2000">{{Citation |last1 = Levine | | <ref name="Levine, 2000">{{Citation | ||
| last1 = Levine | first1 = Paul H. | authorlink1 = Paul Levine | |||
| last2 = Pilkington | first2 = Deborah | authorlink2 = | |||
| last3 = Strickland | first3 = Paula | authorlink3 = | |||
| last4 = Peterson | first4 = Daniel | authorlink4 = Daniel Peterson | |||
| title = Chronic Fatigue Syndrome and Cancer | | title = Chronic Fatigue Syndrome and Cancer | ||
| journal = Journal of Chronic Fatigue Syndrome | volume = 7 | issue = 1 | page = 29-38 | | journal = Journal of Chronic Fatigue Syndrome | volume = 7 | issue = 1 | page = 29-38 | ||
Line 145: | Line 243: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Nagy-Szakal, 2017">{{Citation |last1 = Nagy-Szakal | | <ref name="Nagy-Szakal, 2017">{{Citation | ||
| last1 = Nagy-Szakal | first1 = Dorottya | authorlink1 = Dorottya Nagy-Szakal | |||
| last2 = Williams | first2 = Brent L. | authorlink2 = | |||
| last3 = Mishra | first3 = Nischay | authorlink3 = | |||
| last4 = Che | first4 = Xiaoyu | authorlink4 = | |||
| last5 = Lee | first5 = Bohyun | authorlink5 = | |||
| last6 = Bateman | first6 = Lucinda | authorlink6 = Lucinda Bateman | |||
| last7 = Klimas | first7 = Nancy G. | authorlink7 = Nancy Klimas | |||
| last8 = Komaroff | first8 = Anthony L. | authorlink8 = Anthony Komaroff | |||
| last9 = Levine | first9 = Susan | authorlink9 = Susan Levine | |||
| last10 = Montoya | first10 = Jose G. | authorlink10 = Jose Montoya | |||
| last11 = Peterson | first11 = Daniel L. | authorlink11 = Daniel Peterson | |||
| last12 = Ramanan | first12 = Devi | authorlink12 = | |||
| last13 = Jain | first13 = Komal | authorlink13 = | |||
| last14 = Eddy | first14 = Meredith L. | authorlink14 = | |||
| last15 = Hornig | first15 = Mady | authorlink15 = Mady Hornig | |||
| last16 = Lipkin | first16 = W. Ian | authorlink16 = Ian Lipkin | |||
| title = Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome | | title = Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome | ||
| journal = Microbiome | volume = 5 | issue = 44 | page = | | journal = Microbiome | volume = 5 | issue = 44 | page = | ||
Line 153: | Line 267: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Nagy-Szakal, 2018">{{Citation |last1 = Nagy-Szakal | | <ref name="Nagy-Szakal, 2018">{{Citation | ||
| last1 = Nagy-Szakal | first1 = Dorottya | authorlink1 = Dorottya Nagy-Szakal | |||
| last2 = Barupal | first2 = Dinesh K. | authorlink2 = | |||
| last3 = Lee | first3 = Bohyun | authorlink3 = | |||
| last4 = Che | first4 = Xiaoyu | authorlink4 = | |||
| last5 = Williams | first5 = Brent L. | authorlink5 = | |||
| last6 = Kahn | first6 = Ellie J. R. | authorlink6 = | |||
| last7 = Ukaigwe | first7 = Joy E. | authorlink7 = | |||
| last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman | |||
| last9 = Klimas | first9 = Nancy G. | authorlink9 = Nancy Klimas | |||
| last10 = Komaroff | first10 = Anthony L. | authorlink10 = Anthony Komaroff | |||
| last11 = Levine | first11 = Susan | authorlink11 = Susan Levine | |||
| last12 = Montoya | first12 = Jose G. | authorlink12 = Jose Montoya | |||
| last13 = Peterson | first13 = Daniel L. | authorlink13 = Daniel Peterson | |||
| last14 = Levin | first14 = Bruce | authorlink14 = Bruce Levin | |||
| last15 = Hornig | first15 = Mady | authorlink15 = Mady Hornig | |||
| last16 = Fiehn | first16 = Oliver | authorlink16 = | |||
| last17 = Lipkin | first17 = W. Ian | authorlink17 = Ian Lipkin | |||
| title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | | title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | ||
| journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | | journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | ||
Line 161: | Line 292: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Peterson, 2015">{{Citation |last1 = Peterson | | <ref name="Peterson, 2015">{{Citation | ||
| last1 = Peterson | first1 = D | authorlink1 = Daniel Peterson | |||
| last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | |||
| last3 = Gottschalk | first3 = G | authorlink3 = Gunnar Gottschalk | |||
| last4 = Ramos | first4 = SB | authorlink4 = Sandra Ramos | |||
| last5 = Nguyen | first5 = T | authorlink5 = | |||
| last6 = Staines | first6 = D | authorlink6 = Donald Staines | |||
| last7 = Marshall-Gradisnik | first7 = S | authorlink7 = Sonya Marshall-Gradisnik | | last7 = Marshall-Gradisnik | first7 = S | authorlink7 = Sonya Marshall-Gradisnik | ||
| title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | | title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | ||
Line 169: | Line 306: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Strayer,1995">{{Citation |last1 = Strayer | | <ref name="Strayer,1995">{{Citation | ||
| last1 = Strayer | first1 = DR | authorlink1 = David Strayer | |||
| last2 = Carter | first2 = W | authorlink2 = William Carter | |||
| last3 = Strauss | first3 = KI | authorlink3 = Kenneth Strauss | |||
| last4 = Brodsky | first4 = I | authorlink4 = | |||
| last5 = Suhadolnik | first5 = R | authorlink5 =Robert Suhadolnik | |||
| last6 = Ablashi | first6 = D | authorlink6 = Dharam Ablashi | |||
| last7 = Henry | first7 = B | authorlink7 = | |||
| last8 = Mitchell | first8 = WM | authorlink8 = William Mitchell | |||
| last9 = Bastien | first9 = S | authorlink9 =Sheila Bastien | |||
| last10 = Peterson | first10 = D | authorlink10 = Daniel Peterson | |||
| title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen | | title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen | ||
| journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | | journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | ||
Line 176: | Line 323: | ||
|url=|pages=|chapter=|edition=|isbn=}} | |url=|pages=|chapter=|edition=|isbn=}} | ||
</ref> | </ref> | ||
<ref name="Strayer, 2012">{{Citation |last1 = Strayer | | <ref name="Strayer, 2012">{{Citation | ||
| last9 = Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = | | last1 = Strayer | first1 = DR | authorlink1 = David Strayer | ||
| last2 = Carter | first2 = WA | authorlink2 = William Carter | |||
| last3 = Stouch | first3 = BC | authorlink3 = | |||
| last4 = Stevens | first4 = SR | authorlink4 = Staci Stevens | |||
| last5 = Bateman | first5 = L | authorlink5 = Lucinda Bateman | |||
| last6 = Cimoch | first6 = PJ | authorlink6 = | |||
| last7 = Lapp | first7 = CW | authorlink7 =Charles Lapp | |||
| last8 = Peterson | first8 = DL | authorlink8 = Daniel Peterson | |||
| last9 = Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = | |||
| last10 = Mitchell | first10 = WM | authorlink10 = William Mitchell | |||
| title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | | title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | ||
| journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | | journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | ||
Line 185: | Line 341: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Unger, 2017">{{Citation |last1 = Unger | | <ref name="Unger, 2017">{{Citation | ||
| last18 = Fitzpatrick | first18 = Trisha | authorlink18 = | | last1 = Unger | first1 = Elizabeth R. | authorlink1 = Elizabeth Unger | ||
| last2 = Lin | first2 = Jin-Mann S. | authorlink2 = Jin-Mann Sally Lin | |||
| last3 = Tian | first3 = Hao | authorlink3 = | |||
| last4 = Natelson | first4 = Benjamin H | authorlink4 = Benjamin Natelson | |||
| last5 = Lange | first5 = Gudrun | authorlink5 = Gudrun Lange | |||
| last6 = Vu | first6 = Diana | authorlink6 = | |||
| last7 = Blate | first7 = Michelle | authorlink7 = | |||
| last8 = Klimas | first8 = Nancy G. | authorlink8 = Nancy Klimas | |||
| last9 = Balbin | first9 = Elizabeth G. | authorlink9 = Elizabeth Balbin | |||
| last10 = Bateman | first10 = Lucinda | authorlink10 = Lucinda Bateman | |||
| last11 = Allen | first11 = Ali | authorlink11 = | |||
| last12 = Lapp | first12 = Charles W. | authorlink12 = Charles Lapp | |||
| last13 = Springs | first13 = Wendy | authorlink13 = | |||
| last14 = Kogelnik | first14 = Andreas M. | authorlink14 = Andreas Kogelnik | |||
| last15 = Phan | first15 = Catrina C. | authorlink15 = | |||
| last16 = Danver | first16 = Joan | authorlink16 = | |||
| last17 = Podell | first17 = Richard N. | authorlink17 = Richard Podell | |||
| last18 = Fitzpatrick | first18 = Trisha | authorlink18 = | |||
| last19 = Peterson | first19 = Daniel L. | authorlink19 = Daniel Peterson | |||
| last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | | last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | ||
| last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan | | last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan |
Revision as of 04:43, May 11, 2022
Daniel L. Peterson, MD, is a physician in Incline Village, Nevada specializing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He was at the epicenter of the 1984 Incline Village chronic fatigue syndrome outbreak[1] and continues to be a leader in treatment and research about ME/CFS, serving on Simmaron Research’s Scientific Advisory Board and the Faculty of Health Sciences and Medicine at Griffith University in Queensland, Australia.[2]
He helped establish the Whittemore Peterson Institute (WPI) which was renamed in 2016 the Nevada Center for Biomedical Research.[3] He left in 2010 to return to private practice at Sierra Internal Medicine, Incline Village, Nevada.[4] In 2019, he joined the scientific advisory board of the Open Medicine Foundation.[5]
Dr. Peterson was the first physician to use Ampligen, an immunomodulator made by AIM ImmunoTech (formerly Hemispherx Biopharma), in the treatment for ME/CFS, using it on Nancy Kaiser, a very severe patient.[6] He has participated in every Ampligen trial since, up to the AMP-511, open label, cost-recovery trial available today.[7]
Several documentaries about myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have featured Dr. Peterson, including, I Remember Me and Forgotten Plague, and the news feature, Sick and Tired.
Awards[edit | edit source]
- 2003, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by IACFS/ME[8]
- 2007, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by IACFS/ME[8]
Writing committees[edit | edit source]
- 2003, Canadian Consensus Criteria - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[9] (Full Text)
- 2015, IOM Committee on Diagnostic Criteria for ME/CFS - Dr Peterson was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[10]
Notable studies[edit | edit source]
- 1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection[11] (Abstract)
- 1992, Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome[12] (Abstract - can request full article)
- 1995, Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen[13] (Abstract)
- 1997, Editorial - Chronic Fatigue Syndrome and Disability[14] (Abstract)
- 2000, Chronic Fatigue Syndrome and Cancer[15] (Abstract)
- 2001, Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an Outbreak [16] (Abstract)
- 2003, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[17] (Full Text)
- 2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway[18] (Full Text)
- 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus[19] (Abstract)
- 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome[20] (Full Text)
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[21] (Full Text)
- 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[22] (Full Text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[23] (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[24] (Abstract)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[25] - (Full text)
- 2016, Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome[26] (Abstract)
- 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome[27] (Full Text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[28] (Full Text)
- 2017, Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations[29] (Full Text)
- 2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[30] (Full text)
- 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics[31] (Full Text)
- 2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations[32] - (Full text)
Talks and interviews[edit | edit source]
ME/CFS Alert[edit | edit source]
- 2012, Episode 26, ME/CFS Alert interview
- 2013, Episode 50, ME/CFS Alert interview
Invest in ME International ME Conference[edit | edit source]
- 2007, Speaker on Day 1 of the 2nd Invest in ME International ME Conference on Experiences of Research into ME/CFS: Past, Present, and Future - (Video)
- 2007, Speaker on Day 2 of the 2nd Invest in ME International ME Conference on Clinical Research - (Video)
- 2009, Speaker at the 4th Invest in ME International ME Conference on Treatment Regimes for the Most Severe Cases[33] DVD available
- 2012, Speaker at the 7th Invest in ME International ME Conference on Clinical Research Update 2012[34] DVD available
- 2013, Speaker at the 8th Invest in ME International ME Conference on Key Note Speech: The Mainstreaming of ME Research[35] DVD available
Other[edit | edit source]
- 1996, Primetime Live TV Show - Sick and Tired - Incline Village Outbreak[36]
- 2000 Documentary, I Remember Me, directed by Kim A. Snyder[37]
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 2
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 1
- 2012, Phoenix Rising - Dr Daniel Peterson (July 12)
- 2015, 2015 De osynliga -Seminarium om ME/CFS, Sweden 19 October
- 2017, Solve ME/CFS Initiative’s 2nd Annual Discovery Forum: Presentation by Dr. Dan Peterson
Online presence[edit | edit source]
See also[edit | edit source]
- Ampligen
- Sierra Internal Medicine
- 1984 Incline Village chronic fatigue syndrome outbreak
- Paul Cheney
- List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks
- Canadian Consensus Criteria
Learn more[edit | edit source]
- Wikipedia - Daniel Peterson (physician)
- 1990, Chronic Fatigue Syndrome
- 2019, A Town for People with Chronic Fatigue Syndrome - New Yorker - about Ampligen
References[edit | edit source]
- ↑ "Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising". Health Rising. Retrieved August 13, 2018.
- ↑ "Collaborators - Simmaron Research". Simmaron Research. Retrieved August 13, 2018.
- ↑ "About Us". Nevada Center for Biomedical Research. Retrieved April 13, 2022.
- ↑ "History of Changes for Study: NCT00215813 | Study of Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. April 8, 2010. Retrieved April 13, 2020.
- ↑ "Daniel L. Peterson, MD". Open Medicine Foundation. Retrieved April 1, 2019.
- ↑ "TREATING THE DISEASE, NOT THE SYMPTOMS: NCF'S RESEARCH MOVES CFIDS/ME ONE STEP CLOSER TO NEOPLASTIC DISEASE PROCESS". www.ncf-net.org. Retrieved August 13, 2018.
- ↑ "Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. Retrieved August 13, 2018.
- ↑ 8.0 8.1 "IACFS/ME Awardees". IACFS/ME. Retrieved April 23, 2020.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ https://www.nap.edu/resource/19012/MECFS_Powerpoint.pdf
- ↑ Buchwald, Dedra; Cheney, Paul R.; Peterson, Daniel L.; Henry, Berch; Wormsley, Susan B.; Geiger, Ann; Ablashi, Dharam V.; Salahuddin, S. Zaki; Saxinger, Carl; Biddle, Royce; Kikinis, Ron; Jolesz, Ferenc A.; Folks, Thomas; Balachandran, N.; Peter, James B.; Gallo, Robert C.; Komaroff, Anthony L. (1992), "A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection", Annals of Internal Medicine, 116 (2): 103-113, PMID 1309285
- ↑ Levine, Paul H.; Jacobson, Steven; Pocinki, Alan G.; Cheney, Paul; Peterson, Daniel; Connelly, Roger R; Weil, R; Robinson, SM; Ablashi, Dharam V; Salahuddin, Sayeef Z; Pearson, GR; Hoover, R (1992), "Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome", Archives of Internal Medicine, 152 (8): 1611-1616, doi:10.1001/archinte.1992.00400200049009
- ↑ Strayer, DR; Carter, W; Strauss, KI; Brodsky, I; Suhadolnik, R; Ablashi, D; Henry, B; Mitchell, WM; Bastien, S; Peterson, D (1995), "Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen", Journal of Chronic Fatigue Syndrome, 1 (1): 35-53, doi:10.1300/J092v01n01_04
- ↑ Peterson, Daniel L. (January 1997). "Chronic Fatigue Syndrome and Disability". Journal of Chronic Fatigue Syndrome. 3 (4): 5–7. doi:10.1300/j092v03n04_02. ISSN 1057-3321.
- ↑ Levine, Paul H.; Pilkington, Deborah; Strickland, Paula; Peterson, Daniel (2000), "Chronic Fatigue Syndrome and Cancer", Journal of Chronic Fatigue Syndrome, 7 (1): 29-38, doi:10.1300/J092v07n01_04
- ↑ Strickland, Paula S.; Levine, Paul H.; Peterson, Daniel L.; O'Brien, Karen; Fears, Thomas (January 2001). "Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California". Journal of Chronic Fatigue Syndrome. 9 (3–4): 3–14. doi:10.1300/j092v09n03_02. ISSN 1057-3321.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ Suhadolnik, Robert J.; Peterson, Daniel L.; Reichenbach, Nancy L.; Roen, Gail; Metzger, Melodie; McCahan, John; O'brien, Karen; Welsch, Suzanne; Gabriel, Jerome; Gaughan, John P.; McGregor, Neil R. (2004). "Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway". Journal of Chronic Fatigue Syndrome. 12 (1): 5–35. doi:10.1300/J092v12n01_02.
- ↑ Alter, Harvey J.; Mikovits, Judy A.; Switzer, William M.; Ruscetti, Francis W.; Lo, Shyh-Ching; Klimas, Nancy; Komaroff, Anthony L.; Montoya, Jose G.; Bateman, Lucinda; Levine, Susan; Peterson, Daniel; Levin, Bruce; Hanson, Maureen R.; Genfi, Afia; Bhat, Meera; Zheng, HaoQiang; Wang, Richard; Li, Bingjie; Hung, Guo-Chiuan; Lee, Li Ling; Sameroff, Stephen; Heneine, Walid; Coffin, John; Hornig, Mady; Lipkin, W. Ian (2012), "A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus", mBio, 3 (5): e00266–12, doi:10.1128/mBio.00266-12
- ↑ Strayer, DR; Carter, WA; Stouch, BC; Stevens, SR; Bateman, L; Cimoch, PJ; Lapp, CW; Peterson, DL; Chronic Fatigue Syndrome AMP-516 Study Group; Mitchell, WM (2012), "A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.", PLoS One, 7 (3): e31334, doi:10.1371/journal.pone.0031334, PMID 22431963
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ Peterson, D; Brenu, EW; Gottschalk, G; Ramos, SB; Nguyen, T; Staines, D; Marshall-Gradisnik, S (2015), "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Mediators of Inflammation, 2015, doi:10.1155/2015/929720
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
- ↑ Bateman, L.; Darakjy, S.; Klimas, N.; Peterson, D.; Levine, S.M.; Allen, A.; Carlson, S.A.; Balbin, E.G.; Gottschalk, G.; March, D. (2015), "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study", Fatigue: Biomedicine, Health & Behavior, 3 (1): 1-15, doi:10.1080/21641846.2014.978109
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ Hornig, M; Gottschalk, G; Peterson, D; Knox, KK; Schultz, AF; Eddy, ML; Che, X; Lipkin, WI (2016), "Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.", Molecular Psychiatry, 21 (2): 261-9, doi:10.1038/mp.2015.29
- ↑ Nagy-Szakal, Dorottya; Williams, Brent L.; Mishra, Nischay; Che, Xiaoyu; Lee, Bohyun; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Ramanan, Devi; Jain, Komal; Eddy, Meredith L.; Hornig, Mady; Lipkin, W. Ian (2017), "Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome", Microbiome, 5 (44), doi:10.1186/s40168-017-0261-y
- ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ Hornig, M; Gottschalk, G; Eddy, ML; Che, X; Ukaigwe, JE; Peterson, DL; Lipkin, WI (2017), "Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations", Translational Psychiatry, 7 (4), doi:10.1038/tp.2017.44
- ↑ Marshall-Gradisnik, Sonya; Fretel, Marshall; Eaton, Natalie; Cabanas, Helene; Balinas, Cassandra; Gopalan, Vinod; Petersen, Daniel; Passmore, Rachel; Tang, Kevin; Haque, Mazhar; Lam, Alfred; Staines, Donald (May 31, 2018). "Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Clinical Medicine. 09 (05): 467. doi:10.4236/ijcm.2018.95040.
- ↑ Nagy-Szakal, Dorottya; Barupal, Dinesh K.; Lee, Bohyun; Che, Xiaoyu; Williams, Brent L.; Kahn, Ellie J. R.; Ukaigwe, Joy E.; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Levin, Bruce; Hornig, Mady; Fiehn, Oliver; Lipkin, W. Ian (2018), "Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics", Scientific Reports, 8 (1): 10056, doi:10.1038/s41598-018-28477-9
- ↑ Mandarano, Alexandra H.; Maya, Jessica; Giloteaux, Ludovic; Peterson, Daniel L.; Maynard, Marco; Gottschalk, C. Gunnar; Hanson, Maureen R.; Maureen Hanson (February 10, 2020). "Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations". Journal of Clinical Investigation. 130 (3): 1491–1505. doi:10.1172/jci132185.
- ↑ "Invest in ME Research - IIMEC4". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC7 International ME Conference 2012". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC8 International ME Conference 2013". Invest in ME Research. Retrieved February 4, 2020.
- ↑ CFS and the CDC's Failure to Respond: Primetime Live (1996), retrieved February 4, 2020
- ↑ I Remember Me, retrieved February 4, 2020